38 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
1 Recruiting Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Procedure: Aminolevulinic acid based photodynamic therapy
2 Recruiting Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
Condition: Actinic Keratosis
Interventions: Drug: SR-T100  gel;   Drug: Vehicle gel
3 Recruiting Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Vehicle;   Drug: A-101 (40) Topical Solution;   Drug: A-101 (32.5) Topical Solution
4 Recruiting Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: SR-T100 gel
5 Not yet recruiting Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Procedure: Topical retinoid and blue-light therapy with photosensitizing agent;   Procedure: Photodynamic Therapy (PDT)
6 Unknown  Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Condition: Actinic Keratoses
Interventions: Other: photodynamic therapy;   Drug: imiquimod 5% cream
7 Recruiting Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 2%HAL With 16%MAL
Condition: Actinic Keratoses
Interventions: Drug: Hexylaminolaevulinate cream;   Drug: Methylaminolaevulinate cream
8 Recruiting Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 1.0% of SM;   Drug: SR-T100 with 2.3% of SM
9 Recruiting Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
10 Recruiting Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + ALA Photodynamic Therapy
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid;   Drug: Topical Solution Vehicle;   Device: BLU-U;   Procedure: Cryotherapy
11 Recruiting Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid (ALA);   Drug: Topical Solution Vehicle;   Device: BLU-U Blue Light Photodynamic Therapy Illuminator
12 Unknown  Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
13 Recruiting Treating Actinic Keratoses With Natural Daylight PDT: Comparing Two Light Sensitizers (ALA and MAL)
Condition: Actinic Keratoses (gr I-III)
Interventions: Drug: ALA sensitizer;   Drug: MAL sensitizer
14 Recruiting Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
15 Recruiting Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate
16 Not yet recruiting Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: Pretreatment with CO2 laser before photodynamic therapy;   Device: Only photodynamic therapy
17 Recruiting Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
18 Recruiting A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 Formulation 1;   Drug: LEO 43204 Formulation 2;   Drug: LEO 43204 Formulation 1 Dose X;   Drug: LEO 43204 Formulation 1 Dose Y;   Drug: LEO 43204 Formulation 2 Dose XX;   Drug: LEO 43204 Formulation 2 Dose YY;   Drug: Placebo Formulation 1;   Drug: Placebo Formulation 2
19 Recruiting Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
20 Recruiting Evaluation of a Topical Treatment for Actinic Keratosis
Condition: Actinic Keratosis of Face and Scalp
Interventions: Drug: AD17137 topical treatment;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results
Indicates status has not been verified in more than two years